Back to Careers

Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline

Back to Careers

AI Excellence: Juvena’s JuvNET Platform Recognized as CEO Dr. Yousef Makes Prestigious Mayfield | Divot AI List

Back to Careers

Pharmaphorum Spotlights Juvena’s AI Platform for Muscle and Metabolic Regeneration in Interview with CEO, Dr. Hanadie Yousef

Back to Careers

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Back to Careers

Lilly Bites Again in $650M Muscle-Preserving Treatment Pact With Juvena

Back to Careers

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs

Back to Careers

Juvena Kicks Off First Human Trial of Muscle Regeneration Therapy

Back to Careers

Our CEO, Hanadie Yousef, discussed Juvena’s growing and advancing pipeline of tissue restorative biologics for myopathies and obesity with Miranda Schmalfuhs from Pharmaceutical Executive

Back to Careers

Healthspan Capital highlights Juvena Therapeutics in its LongBio Report comprehensively profiling the leading companies in longevity biotechnology

Back to Careers

CEO Dr. Hanadie Yousef was nominated to Founders Forum’s 100 Women Founders to Watch,  which shines a light on 100 of the most exceptional women founders blazing a trail in the tech industry across UK & Europe, the United States, and Southeast Asia